Theravance Biopharma is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Our pipeline of internally discovered programs is targeted to address significant patient needs. Our research is focused in the areas of inflammation and immunology. We have one approved product, YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Theravance Biopharma US Address
901 Gateway Blvd. South San Francisco, CA United States
Theravance Biopharma US Email
Past Companies
Theravance Biopharma US, Inc.Head of Investor Relations
AgenusChief External Affairs & Communications Officer